抵抗素在肝脏胰岛素抵抗中的作用及其机制探讨  

The role of resistin in hepatic insulin resistance and the underlying mechanism

作　　者：李焱[1] 何娟[2] 李芳萍[1] 刘珊英[1] 罗招凡[1] 黎峰[1] 刘丹[1] 徐明彤[1] 严励[1] 

机构地区：[1]中山大学附属第二医院内分泌科,广东广州510120 [2]贵阳医学院附属医院内分泌科,贵州贵阳550004

出　　处：《中国药理学通报》2009年第2期190-193,共4页Chinese Pharmacological Bulletin

基　　金：2006年国家自然科学基金资助项目(No30570886);2006年广东省自然科学基金资助项目(No6021329);2003年教育部回国人员启动基金资助项目

摘　　要：目的探讨抵抗素在肝脏胰岛素抵抗中的作用及其可能的机制。方法将载有抵抗素基因的重组腺病毒经尾静脉注射构建高抵抗素血症小鼠模型,同时设正常对照组及病毒对照组,取肝脏组织切片行PAS糖原染色半定量观察肝糖代谢变化;以Western blot检测肝腺苷酸活化蛋白激酶(AMPK)的磷酸化,以磷酸化AMPK/总AMPK的比值代表AMPK激活程度;以实时PCR检测肝组织糖异生关键酶葡萄糖6磷酸酶(G6Pase)和磷酸烯醇式丙酮酸羧激酶(PEP-CK)mRNA表达水平的变化。结果重组腺病毒注射d5获得血中抵抗素高表达构建了高抵抗素血症动物模型,糖原染色示高抵抗素血症小鼠肝糖原含量较正常对照及病毒对照组降低(P<0.05);高抵抗素血症组肝AMPK磷酸化水平较正常对照及病毒对照组下降,磷酸化AMPK/总AMPK比值分别为0.78±0.06vs0.93±0.13,0.89±0.05(P<0.05)。高抵抗素血症小鼠G6Pase和PEPCK的mRNA表达升高,G6Pase分别为2.136±0.857vs1.353±0.49,1.250±0.77;PEPCK分别为3.54±0.90vs2.75±0.78,2.63±0.67(P<0.05)。结论抵抗素可能通过抑制肝脏AMPK活性,增加肝糖异生关键酶的表达而影响机体肝糖代谢,降低肝糖储量,参与肝脏胰岛素抵抗的形成。Aim To investigate the role of resistin in hepatic insulin resistance and its mechanism. Methods We established a mouse model of hyperresistinemia in C57BL/6 mice by intravenous administration of the recombinant adenovirus encoding mouse resistin. Using periodic acid-Schiff staining we observed the effects of resistin on the hepatic glycogen storage. Western blot was used to measure AMPK-protein and phosphrylated AMPK-（ Thr172 ） protein, mRNA level of phosphoenolpyruvate carboxykinase gene and glucose-6- phosphatase gene was measured by real-time PCR. Re- sults On the fifth day after Adv injection, the concentration of plasma resistin was much higher in Advresistin-EGFP-treated mice than in saline-or Adv-EGFP-treated mice. The semiquantitation of hepatic glucogen storage by PAS showed that the mice with hyperresistinemia had decreased glycogen particles compared with normal control and Adv-EGFP groups. The ratio of phosphorylated AMPK（ Thr172）-to total AMPK-was used to evaluate hepatic AMPK activation. Compared with normal control and Adv-EGFP groups, the Advresistin-EGFP-treated mice had significantly lower ratio of p-AMPK/AMPK, and higher expression levels of G6Pase and PEPCK mRNA in liver. Conclusion Resistin may decrease AMPK activation with downregulated expression of gluconeogenic enzymes, resulting in increased glucose production and decreased hepatic glycogen storage. Resistin may play an important role in hepatic insulin resistance.

关 键 词：肝脏胰岛素抵抗 抵抗素 磷酸烯醇式丙酮酸羧激酶 腺苷酸活化蛋白激酶 正常对照组 重组腺病毒 磷酸化水平 mRNA表达 

分 类 号：R644[医药卫生—外科学] R587.1[医药卫生—临床医学]